PE anti-mouse Ly-6G Antibody

Pricing & Availability
Clone
1A8 (See other available formats)
Regulatory Status
RUO
Other Names
Lymphocyte antigen 6 complex, locus G
Isotype
Rat IgG2a, κ
Ave. Rating
Submit a Review
Product Citations
publications
1A8_PE_090808.jpg
C57BL/6 bone marrow cells stained with 1A8 PE (gated on myeloid cells)
  • 1A8_PE_090808.jpg
    C57BL/6 bone marrow cells stained with 1A8 PE (gated on myeloid cells)
Compare all formats See PE spectral data
Cat # Size Price Quantity Check Availability Save
127607 50 µg 108€
Check Availability


Need larger quantities of this item?
Request Bulk Quote
127608 200 µg 227€
Check Availability


Need larger quantities of this item?
Request Bulk Quote
Description

Lymphocyte antigen 6 complex, locus G (Ly-6G), a 21-25 kD GPI-anchored protein, is expressed on the majority of myeloid cells in bone marrow and peripheral granulocytes.

Product Details
Technical data sheet

Product Details

Verified Reactivity
Mouse
Antibody Type
Monoclonal
Host Species
Rat
Immunogen
Ly-6G transfected EL-4J cell line.
Formulation
Phosphate-buffered solution, pH 7.2, containing 0.09% sodium azide.
Preparation
The antibody was purified by affinity chromatography, and conjugated with PE under optimal conditions.
Concentration
0.2 mg/ml
Storage & Handling
The antibody solution should be stored undiluted between 2°C and 8°C.
Application

FC - Quality tested

Recommended Usage

Each lot of this antibody is quality control tested by immunofluorescent staining with flow cytometric analysis. For flow cytometric staining, the suggested use of this reagent is ≤ 0.25 µg per 106 cells in 100 µl volume. It is recommended that the reagent be titrated for optimal performance for each application.

Excitation Laser
Blue Laser (488 nm)
Green Laser (532 nm)/Yellow-Green Laser (561 nm)
Application Notes

While 1A8 recognizes only Ly-6G, clone RB6-8C5 recognizes both Ly-6G and Ly-6C. Clone RB6-8C5 binds with high affinity to mouse Ly-6G molecules and to a lower extent to Ly-6C15. Clone RB6-8C5 impairs the binding of anti-mouse Ly-6G clone 1A815. However, clone RB6-8C5 is able to stain in the presence of anti-mouse Ly-6C clone HK1.416.

Additional reported applications (for the relevant formats) include: immunohistochemistry9 of frozen sections10 and paraffin-embedded sections11, depletion4, 12-14, and spatial biology (IBEX)20,21. The Ultra-LEAF™ purified antibody (Endotoxin < 0.01 EU/µg, Azide-Free, 0.2 µm filtered) is recommended for in vivo studies or highly sensitive assays (Cat. No. 127632, 127649, 127650, 127661 and 127662).

Application References

(PubMed link indicates BioLegend citation)
  1. Fleming TJ, et al. 1993. J. Immunol. 151:2399. (FC)
  2. Daley JM, et al. 2008. J. Leukocyte Biol. 83:1. (FC)
  3. Dietlin TA, et al. 2007. J. Leukocyte Biol. 81:1205. (FC)
  4. Daley J, et al. 2007. J. Leukocyte Biol. doi:10.1189. (Deplete) PubMed
  5. Tadagavadi RK, et al. 2010. J. Immunol. 185:4904. PubMed
  6. Sumagin R, et al. 2010. J. Immunol. 185:7057. PubMed
  7. Guiducci C, et al. 2010. J. Exp Med. 207:2931. PubMed
  8. Fujita M, et al. 2011. Cancer Res. 71:2664. PubMed
  9. Van Leeuwen, et al. 2008. Arterioscler. Thromb. Vasc. Biol. 28:84. (IHC)
  10. Kowanetz M, et al. 2010. P. Natl. Acad. Sci. USA 107:21248. [supplementary data] (IHC)
  11. Esbona K, et al. 2016. Breast Cancer Res. 18:35. (IHC)
  12. Wojtasiak M, et al. 2010. J. Gen. Virol. 91:2158. (FC, Deplete)
  13. Jaeger BN, et al. 2012. J. Exp. Med. 209:565. (Deplete)
  14. Wozniak KL, et al. 2012. BMC Immunol. 13:65 (FC, Deplete)
  15. Ribechini E, et al. 2009. Eur. J. Immunol. 39:3538.
  16. Ng LG, et al. 2011. J Invest. Dermatol. 131:2058. PubMed
  17. Ma C, et al. 2012. J. Leukoc. Biol. 92:1199.
  18. McCartney-Francis, N, et al. 2014. J Leukoc. Biol. 96:917. PubMed
  19. Her Z, et al. 2014. EMBO Mol. Med. 7:24. PubMed
  20. Radtke AJ, et al. 2020. Proc Natl Acad Sci U S A. 117:33455-65. (SB) PubMed
  21. Radtke AJ, et al. 2022. Nat Protoc. 17:378-401. (SB) PubMed
Product Citations
  1. Lee T, et al. 2014. Mol Biol Cell. 25:583. PubMed
  2. Hernández-Santana YE, et al. 2020. Life Sci Alliance. 3:00. PubMed
  3. D'Alessandro G, et al. 2020. Eur J Immunol. 50:705. PubMed
  4. DeSouza-Vieira T, et al. 2020. Cell Rep. 33:108317. PubMed
  5. Bowling S, et al. 2020. Cell. 181(6):1410-1422.e27. PubMed
  6. Combes F, et al. 2018. Neoplasia. 20:848. PubMed
  7. de la Rosa X, et al. 2018. Am J Pathol. 188:950. PubMed
  8. Ramakrishna C, et al. 2019. Nat Commun. 10:2153. PubMed
  9. Sierro F, et al. 2017. Immunity. 47:374. PubMed
  10. Yu X, et al. 2020. Nat Commun. 11:1110. PubMed
  11. Guo H, et al. 2020. Curr Protoc Immunol. 131:e107. PubMed
  12. Liang J, et al. 2021. Cancer Manag Res. 13:6977. PubMed
  13. Zhao D, et al. 2021. Innate Immun. 27:533. PubMed
  14. Zhou R, et al. 2022. EBioMedicine. 75:103762. PubMed
  15. Volmari A, et al. 2021. Hepatol Commun. 5:2104. PubMed
  16. Da Mesquita S, et al. 2021. Nature. 593:255. PubMed
  17. Cai B, et al. 2016. Proc Natl Acad Sci U S A. 113: 6526 - 6531. PubMed
  18. Kozik J, et al. 2016. Sci Rep. 6:28556. PubMed
  19. Herz J, et al. 2015. J Exp Med. 212: 1153 - 1169. PubMed
  20. Jackson A, et al. 2014. J Leukoc Biol. 92:609. PubMed
  21. Jung J, et al. 2019. Cell Host Microbe. 25:513. PubMed
  22. Fachi JL et al. 2019. Cell reports. 27(3):750-761 . PubMed
  23. Alissafi T, et al. 2018. J Clin Invest. 128:3840. PubMed
  24. Iwamoto H et al. 2018. Cell metabolism. 28(1):104-117 . PubMed
  25. Gawish R, et al. 2022. Elife. 11:. PubMed
  26. Li X, et al. 2022. Nat Commun. 13:2794. PubMed
  27. He J, et al. 2022. Front Immunol. 12:760138. PubMed
  28. Ancey PB, et al. 2021. Cancer Res. 81:2345. PubMed
  29. Machata S, et al. 2021. Front Immunol. 11:565869. PubMed
  30. Tang L, et al. 2021. Oncol Lett. 22:605. PubMed
  31. Ajendra J, et al. 2016. Sci Rep. 6:39648. PubMed
  32. Bottek J, et al. 2020. Mucosal Immunol. 1.029166667. PubMed
  33. Sharma K, et al. 2021. Cell Reports. 36(3):109351. PubMed
  34. Zhang Y, et al. 2018. Sci Rep. 8:5994. PubMed
  35. Kenichi Shimada et al. 2018. Immunity. 49(5):873-885 . PubMed
  36. Zhang K, et al. 2018. PLoS Pathog. 14:e1006925. PubMed
  37. Delás MJ, et al. 2019. Cell Rep. 27:719. PubMed
  38. Putnam NE, et al. 2019. PLoS Pathog. 15:e1007744. PubMed
  39. Hanhai Z, et al. 2021. Aging (Albany NY). 13:13108. PubMed
  40. Choi YY, et al. 2021. Cell Death Dis. 12:826. PubMed
  41. Acharya N, et al. 2020. Immunity. 53(3):658-671.e6. PubMed
  42. Clement M, et al. 2016. PLoS Pathog. 12:e1006050. PubMed
  43. Montufar-Solis D, Klein J 2016. PLoS One. 11: 014611. PubMed
  44. Sun P, et al. 2015. J Hepatol. . PubMed
  45. Okada M, et al. 2014. J Biol Chem. 289:32926. PubMed
  46. Lechner AJ et al. 2017. Cell stem cell. 21(1):120-134 . PubMed
  47. Ishii T,et al. 2017. Sci Rep.. 10.1038/s41598-017-12513-1. PubMed
  48. Xie D, et al. 2017. PLoS One. 10.1371/journal.pone.0181454. PubMed
  49. Muhammad W, et al. 2022. Acta Biomater. 148:258. PubMed
  50. Rogic A, et al. 2021. Nat Commun. 12:6889. PubMed
  51. Harding M, et al. 2014. PLoS Pathog. 10:1004379. PubMed
  52. Morales D, et al. 2015. J Virol. 89:337. PubMed
  53. Lin T, et al. 2015. PLoS One. 10: e0138335. PubMed
  54. Iwata H, et al. 2016. Nat Commun. 7:12849. PubMed
  55. Yeo WS, et al. 2020. J Bacteriol. 202:00:00. PubMed
  56. Webster HC, et al. 2020. J Immunol Methods. 112702:477. PubMed
  57. Pham THM, et al. 2020. Cell Host & Microbe. 27(1):54-67.e5.. PubMed
  58. Go DM, et al. 2021. Cell Mol Gastroenterol Hepatol. 12:715. PubMed
  59. Bae SH, et al. 2021. Theranostics. 11:2522. PubMed
  60. Zhou HF, et al. 2022. Front Pharmacol. 13:778755. PubMed
  61. Helm M, et al. 2022. Life (Basel). 12:. PubMed
  62. Dolgova EV, et al. 2022. Int J Mol Sci. 23:. PubMed
  63. Papafragkos I, et al. 2022. Front Immunol. 13:889075. PubMed
  64. Lemon J, et al. 2015. Infect Immun . 83: 3204-3212. PubMed
  65. Zhou Z, et al. 2019. Oxid Med Cell Longev. 2019:1209307. PubMed
  66. Mastandrea I, et al. 2022. STAR Protoc. 3:101106. PubMed
  67. Ma M, et al. 2021. Front Immunol. 12:718779. PubMed
  68. Zhang Z, et al. 2021. Oncoimmunology. 10:1912472. PubMed
  69. Metzger D, et al. 2015. J Infect Dis. 212: 445-452. PubMed
  70. Winkler MJ, et al. 2020. Basic Res Cardiol. 115:67. PubMed
  71. Ku MW, et al. 2020. Cell Host Microbe. 29(2):236-249.e6. PubMed
  72. Ratitong B, et al. 2021. Cell Reports. 35(7):109139. PubMed
  73. Müller A, et al. 2020. J Clin Invest. 5765:130. PubMed
  74. Fujita Y et al. 2018. Cell reports. 24(12):3296-3311 . PubMed
  75. Schaffert A, et al. 2020. Front Immunol. 10:3024. PubMed
  76. Galvão I, et al. 2018. Front Immunol. 9:142. PubMed
  77. Shin SH, et al. 2022. Front Cell Neurosci. 16:844480. PubMed
  78. Zhang J, et al. 2022. iScience. 25:104963. PubMed
  79. Qiu Z, et al. 2016. Sci Rep. 6:31936. PubMed
  80. Kojo K, et al. 2016. Sci Rep. 6:29650. PubMed
  81. Hegde S, et al. 2020. Cancer Cell. 37(3):289-307. PubMed
  82. Al Mamun A, et al. 2019. Neurochem Int. 127:148. PubMed
  83. Deng Z, et al. 2017. Oncogene. 36:639. PubMed
  84. Varol D et al. 2017. Immunity. 46(6):1030-1044 . PubMed
  85. McLaughlin PA et al. 2019. PLoS Pathog. 15(7):e1007847 . PubMed
  86. Linde N, et al. 2018. Nat Commun. 9:21. PubMed
  87. Soto-Díaz K, et al. 2021. Front Immunol. 12:734349. PubMed
  88. El-Zaatari M, et al. 2014. J Immunol. 193:807. PubMed
  89. Hulsmans M et al. 2017. Cell. 169(3):510-522 . PubMed
  90. Si Y, et al. 2018. J Control Release. 282:120. PubMed
  91. Du Y, et al. 2022. Nat Commun. 13:231. PubMed
  92. Catani J, et al. 2016. Transl Oncol. 9:565-574. PubMed
  93. Markman JL, et al. 2020. Nat Commun. 11:1613. PubMed
  94. Wheeler MA, et al. 2019. Cell. 176:581. PubMed
  95. Steuerman Y et al. 2018. Cell systems. 6(6):679-691 . PubMed
  96. Zhou Z, et al. 2022. Life (Basel). 12:. PubMed
  97. Yong L, et al. 2022. Nat Commun. 13:4255. PubMed
  98. Coquery C, et al. 2014. PLoS One. 9:102284. PubMed
  99. Umeshappa CS, et al. 2021. Cell Reports. 34(13):108919. PubMed
  100. Abe M, et al. 2020. Clin Exp Immunol. 303:199. PubMed
  101. Zhou G, et al. 2019. FASEB J. 33:11396. PubMed
  102. Su M, et al. 2022. Nat Cardiovasc Res. 1:732. PubMed
  103. Frenis K, et al. 2021. Basic Res Cardiol. 31:116. PubMed
  104. Unudurthi SD, et al. 2020. Life Sci. 117440:247. PubMed
  105. Finsterbusch M, et al. 2014. J Exp Med. 211:1307. PubMed
  106. Vergadi E, et al. 2014. J Immunol. 192:394. PubMed
  107. Kim Y, et al. 2012. J Immunol. 188:4226. PubMed
  108. Yamada KJ, et al. 2020. PLoS Pathog. 16:e1008354. PubMed
  109. Rynkiewicz NK, et al. 2020. Sci Signal. 13:. PubMed
  110. Gopinath A, et al. 2022. NPJ Parkinsons Dis. 8:72. PubMed
  111. Sanmarco LM, et al. 2021. Nature. 590:473. PubMed
  112. Daneshmandi S, et al. 2021. Elife. 10:. PubMed
  113. Tapia-Abellán A, et al. 2021. Sci Adv. 7:eabf4468. PubMed
  114. Jiang Y, et al. 2021. Cell Death Differ. 28:3009. PubMed
  115. Uematsu T, et al. 2016. Sci Rep. 6:37815. PubMed
  116. Takesue S, et al. 2020. Int J Oncol. 56:596. PubMed
  117. Kimura H, et al. 2019. Sci Rep. 9:5887. PubMed
  118. Hsu BE et al. 2019. Cell Rep. 27(13):3902-3915 . PubMed
  119. Su W et al. 2019. Cancer Cell. 36(2):139-155 . PubMed
  120. Bronisz–Budzynska I, et al. 2019. Skelet Muscle. 9:22. PubMed
  121. Gamrekelashvili J, et al. 2021. Bio Protoc. 11:e4007. PubMed
  122. Takizawa S, et al. 2022. Mol Med. 28:91. PubMed
  123. Ryan NM, et al. 2022. Front Immunol. 13:932742. PubMed
  124. Wang G, et al. 2021. Cell Host Microbe. 29(5):777-791.e6. PubMed
  125. Swanson P, et al. 2016. PLoS Pathog. 12:e1006022. PubMed
  126. Kim M, et al. 2018. Immunity. 49:151. PubMed
  127. Petkevicius K, et al. 2019. Elife. 8:e47990. PubMed
  128. Baomei Wang et al. 2019. Cell reports. 26(6):1614-1626 . PubMed
  129. Matsumura T, et al. 2022. Nat Commun. 13:7064. PubMed
  130. Murray MP, et al. 2022. Cell Rep. 38:110209. PubMed
  131. Wang W, et al. 2021. J Am Heart Assoc. 10:e019142. PubMed
  132. Penke LR, et al. 2020. Life Sci Alliance. 3:. PubMed
  133. Liu Y, et al. 2015. BioMed Res Int. 2015 563425. PubMed
  134. Jiang L, et al. 2020. Cell. 183(5):1219-1233.e18. PubMed
  135. Onai N, et al. 2020. Int J Mol Sci. :22. PubMed
  136. Wang T et al. 2018. Immunity. 49(3):504-514 . PubMed
  137. Laban H, et al. 2018. J Cell Biol. 217:1503. PubMed
  138. Chiang N, et al. 2019. J Clin Invest. 129:5294. PubMed
  139. Eislmayr K, et al. 2022. Sci Adv. 8:eabj7293. PubMed
  140. Unsinger J, et al. 2021. J Leukoc Biol. 109:697. PubMed
  141. Vaibhav K, et al. 2020. Sci Adv. 6:eaax8847. PubMed
  142. Huang W, et al. 2016. Cell Death Differ. 10.1038/cdd.2016.115. PubMed
  143. Buerfent BC, et al. 2019. GMS Infect Dis. 7:Doc04. PubMed
  144. Grayczyk JP et al. 2017. Cell host & microbe. 22(5):678-687 . PubMed
  145. Clemente–Casares X, et al. 2017. Immunity. 47:974. PubMed
  146. Zhu YP et al. 2018. Cell reports. 24(9):2329-2341 . PubMed
  147. Sadhu S, et al. 2021. J Immunol. 207:1812. PubMed
  148. Rao L, et al. 2020. Nat Commun. 11:4909. PubMed
  149. Ding R, et al. 2022. J Neuroinflammation. 19:137. PubMed
  150. Zhang W, et al. 2021. Front Immunol. 12:768435. PubMed
  151. Zheng Y, et al. 2022. J Immunol. 208:501. PubMed
  152. Issah Y, et al. 2021. Elife. 10:. PubMed
  153. Kiss M, et al. 2020. Cancer Immunol Res. 9:309. PubMed
  154. Kimura T, et al. 2014. Int Immunol. 26:697. PubMed
  155. Fujimura N, et al. 2016. Sci Rep. 5:11664. PubMed
  156. Hu R, et al. 2015. J Immunol. 195: 4802 - 4809. PubMed
  157. Zhang T, et al. 2020. JCI Insight. 5:00. PubMed
  158. Huang WC, et al. 2020. Adv Mater. 32:e2005637. PubMed
  159. Matsumoto M, et al. 2021. Cell Host Microbe. 29(6):930-940.e4. PubMed
  160. Porrello A, et al. 2018. Nat Commun. 9:1988. PubMed
  161. Kong XF, et al. 2018. Nat Immunol. 19:973. PubMed
  162. Weckbach LT, et al. 2019. J Exp Med. 216:350. PubMed
  163. Subramaniam N, et al. 2021. Blood Adv. 5:1259. PubMed
  164. Li Y, et al. 2022. Theranostics. 12:5364. PubMed
  165. Zhai T, et al. 2020. Clin Exp Pharmacol Physiol. 47:677. PubMed
  166. Xu C, et al. 2021. Cell Reports. 35(11):109235. PubMed
  167. Martins R, et al. 2016. Nat Immunol. 17:1361-1372. PubMed
  168. Guo H, et al. 2016. J Immunol. 196: 2300 - 2308. PubMed
  169. Li Y, et al. 2020. Theranostics. 10:11376. PubMed
  170. Nguyen HX et al. 2017. J Neurosci. 37(38):9269-9287 . PubMed
  171. Moraes JA, et al. 2018. J Innate Immun. 11:330. PubMed
  172. Zhao Z, et al. 2019. J Immunol Res. 2019:9561350. PubMed
  173. Winter C, et al. 2018. Cell Metab. 28:175. PubMed
  174. Hirota K et al. 2018. Immunity. 48(6):1220-1232 . PubMed
  175. Ishihara J, et al. 2018. Nat Commun. 9:2163. PubMed
  176. Bozoglu T, et al. 2022. Adv Sci (Weinh). 9:e2103867. PubMed
  177. Chen YL, et al. 2022. Front Neurosci. 16:876582. PubMed
  178. Hou Y, et al. 2013. J Nutr Biochem. 24:1555. PubMed
  179. Zhang S, et al. 2016. PLoS Pathog. 12: 1005617. PubMed
  180. Wang J, et al. 2020. Cell. 183(7):1867-1883.e26. PubMed
  181. Heyde A, et al. 2021. Cell. 184(5):1348-1361.e22. PubMed
  182. Wang X, et al. 2021. Immunity. 54(6):1123-1136.e8. PubMed
  183. Schuran FA, et al. 2020. Cell Mol Gastroenterol Hepatol. . PubMed
  184. Wheeler MA, et al. 2020. Nature. 578:593. PubMed
  185. Wang C, et al. 2020. Mucosal Immunol. 13:22. PubMed
  186. Weng JH, et al. 2021. Nat Metab. 3:513. PubMed
  187. Shin SH, et al. 2022. Clin Exp Otorhinolaryngol. . PubMed
  188. Zha ZX, et al. 2022. Acta Pharmacol Sin. :. PubMed
  189. Jia J, et al. 2022. Nat Commun. 13:6804. PubMed
  190. Zhang B, et al. 2021. Front Neurol. 607370:12. PubMed
  191. Uematsu T, et al. 2015. Sci Rep. 5: 17577. PubMed
  192. Rodgers M, et al. 2014. J Exp Med. 211:1333. PubMed
  193. Hellmann J, et al. 2013. J Immunol. 191:1383. PubMed
  194. Ma Y, et al. 2020. Front Immunol. 11:586685. PubMed
  195. Pessoa Rodrigues C, et al. 2020. Sci Adv. 6:eaaz4815. PubMed
  196. Thomson CA, et al. 2018. J Immunol. 201:215. PubMed
  197. Ribechini E, et al. 2017. Blood Adv. 0.699305556. PubMed
  198. Qu J, et al. 2021. Int J Biol Sci. 17:2756. PubMed
RRID
AB_1186104 (BioLegend Cat. No. 127607)
AB_1186099 (BioLegend Cat. No. 127608)

Antigen Details

Structure
A 21-35 kD GPI-anchorded membrane protein
Distribution

Expressed on the majority of myeloid cells in bone marrow and peripheral granulocytes. The monoclonal antibody RB6-8C5 recognizes both Ly-6G and Ly-6C.

Cell Type
Granulocytes, Macrophages, Monocytes
Biology Area
Immunology, Innate Immunity
Antigen References

Fleming TJ, et al. 1993. J. Immunol. 151:2399.

Gene ID
546644 View all products for this Gene ID
UniProt
View information about Ly-6G on UniProt.org

Related FAQs

What type of PE do you use in your conjugates?
We use R-PE in our conjugates.

Other Formats

View All Ly-6G Reagents Request Custom Conjugation
Description Clone Applications
Alexa Fluor® 594 anti-mouse Ly-6G 1A8 IHC-F
Purified anti-mouse Ly-6G 1A8 FC,IHC-F,IHC
Biotin anti-mouse Ly-6G 1A8 FC,IHC
FITC anti-mouse Ly-6G 1A8 FC
PE anti-mouse Ly-6G 1A8 FC
Alexa Fluor® 647 anti-mouse Ly-6G 1A8 FC,IHC-F
Pacific Blue™ anti-mouse Ly-6G 1A8 FC
APC anti-mouse Ly-6G 1A8 FC
PerCP/Cyanine5.5 anti-mouse Ly-6G 1A8 FC
PE/Cyanine7 anti-mouse Ly-6G 1A8 FC
Alexa Fluor® 700 anti-mouse Ly-6G 1A8 FC,IHC
APC/Cyanine7 anti-mouse Ly-6G 1A8 FC
Alexa Fluor® 488 anti-mouse Ly-6G 1A8 FC,IHC-F,SB
Brilliant Violet 421™ anti-mouse Ly-6G 1A8 FC,IHC-F
Brilliant Violet 570™ anti-mouse Ly-6G 1A8 FC
Ultra-LEAF™ Purified anti-mouse Ly-6G 1A8 FC,Depletion,IHC
Brilliant Violet 510™ anti-mouse Ly-6G 1A8 FC
Purified anti-mouse Ly-6G (Maxpar® Ready) 1A8 FC,CyTOF®,WB
Brilliant Violet 650™ anti-mouse Ly-6G 1A8 FC
Brilliant Violet 711™ anti-mouse Ly-6G 1A8 FC
Brilliant Violet 605™ anti-mouse Ly-6G 1A8 FC
Brilliant Violet 785™ anti-mouse Ly-6G 1A8 FC
PE/Dazzle™ 594 anti-mouse Ly-6G 1A8 FC
APC/Fire™ 750 anti-mouse Ly-6G 1A8 FC
PerCP anti-mouse Ly-6G 1A8 FC
TotalSeq™-A0015 anti-mouse Ly-6G 1A8 PG
TotalSeq™-C0015 anti-mouse Ly-6G 1A8 PG
TotalSeq™-B0015 anti-mouse Ly-6G 1A8 PG
Spark Blue™ 550 anti-mouse Ly-6G 1A8 FC
Spark NIR™ 685 anti-mouse Ly-6G 1A8 FC
Spark YG™ 593 anti-mouse Ly-6G 1A8 FC
APC/Fire™ 810 anti-mouse Ly-6G Antibody 1A8 FC
PE/Cyanine5 anti-mouse Ly-6G 1A8 FC
PE/Fire™ 810 anti-mouse Ly-6G Antibody 1A8 FC
Spark UV™ 387 anti-mouse Ly-6G 1A8 FC
PE/Fire™ 640 anti-mouse Ly-6G 1A8 FC
Spark YG™ 570 anti-mouse Ly-6G 1A8 IHC-F,FC
Go To Top Version: 3    Revision Date: 01.06.2017

For research use only. Not for diagnostic use. Not for resale. BioLegend will not be held responsible for patent infringement or other violations that may occur with the use of our products.

 

*These products may be covered by one or more Limited Use Label Licenses (see the BioLegend Catalog or our website, www.biolegend.com/ordering#license). BioLegend products may not be transferred to third parties, resold, modified for resale, or used to manufacture commercial products, reverse engineer functionally similar materials, or to provide a service to third parties without written approval of BioLegend. By use of these products you accept the terms and conditions of all applicable Limited Use Label Licenses. Unless otherwise indicated, these products are for research use only and are not intended for human or animal diagnostic, therapeutic or commercial use.

 

8999 BioLegend Way, San Diego, CA 92121 www.biolegend.com
Toll-Free Phone: 1-877-Bio-Legend (246-5343) Phone: (858) 768-5800 Fax: (877) 455-9587

This data display is provided for general comparisons between formats.
Your actual data may vary due to variations in samples, target cells, instruments and their settings, staining conditions, and other factors.
If you need assistance with selecting the best format contact our expert technical support team.

  • Alexa Fluor® 594 anti-mouse Ly-6G

  • Purified anti-mouse Ly-6G

  • Biotin anti-mouse Ly-6G

  • FITC anti-mouse Ly-6G

  • PE anti-mouse Ly-6G

  • Alexa Fluor® 647 anti-mouse Ly-6G

  • Pacific Blue™ anti-mouse Ly-6G

  • APC anti-mouse Ly-6G

  • PerCP/Cyanine5.5 anti-mouse Ly-6G

  • PE/Cyanine7 anti-mouse Ly-6G

  • Alexa Fluor® 700 anti-mouse Ly-6G

  • APC/Cyanine7 anti-mouse Ly-6G

  • Alexa Fluor® 488 anti-mouse Ly-6G

  • Brilliant Violet 421™ anti-mouse Ly-6G

  • Brilliant Violet 570™ anti-mouse Ly-6G

  • Ultra-LEAF™ Purified anti-mouse Ly-6G

  • Brilliant Violet 510™ anti-mouse Ly-6G

  • Purified anti-mouse Ly-6G (Maxpar® Ready)

  • Brilliant Violet 650™ anti-mouse Ly-6G

  • Brilliant Violet 711™ anti-mouse Ly-6G

  • Brilliant Violet 605™ anti-mouse Ly-6G

  • Brilliant Violet 785™ anti-mouse Ly-6G

  • PE/Dazzle™ 594 anti-mouse Ly-6G

  • APC/Fire™ 750 anti-mouse Ly-6G

  • PerCP anti-mouse Ly-6G

  • TotalSeq™-A0015 anti-mouse Ly-6G

  • TotalSeq™-C0015 anti-mouse Ly-6G

  • TotalSeq™-B0015 anti-mouse Ly-6G

  • Spark Blue™ 550 anti-mouse Ly-6G

  • Spark NIR™ 685 anti-mouse Ly-6G

  • Spark YG™ 593 anti-mouse Ly-6G

  • APC/Fire™ 810 anti-mouse Ly-6G Antibody

  • PE/Cyanine5 anti-mouse Ly-6G

  • PE/Fire™ 810 anti-mouse Ly-6G Antibody

  • Spark UV™ 387 anti-mouse Ly-6G

  • PE/Fire™ 640 anti-mouse Ly-6G

  • Spark YG™ 570 anti-mouse Ly-6G

ProductsHere

Login / Register
Remember me
Forgot your password? Reset password?
Create an Account